Phathom Pharmaceuticals (PHAT) PT Raised to $55 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Alan Carr raised the price target on Phathom Pharmaceuticals (NASDAQ: PHAT) to $55.00 (from $45.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
